Anzeige
Mehr »
Donnerstag, 06.11.2025 - Börsentäglich über 12.000 News
SuperBuzz explodiert um 20% nach Mega-Deal mit NASDAQ-Werberiesen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 502816 | ISIN: GB0009223206 | Ticker-Symbol: NPW1
Xetra
05.11.25 | 17:35
15,840 Euro
-1,61 % -0,260
1-Jahres-Chart
SMITH & NEPHEW PLC Chart 1 Jahr
5-Tage-Chart
SMITH & NEPHEW PLC 5-Tage-Chart
RealtimeGeldBriefZeit
15,86516,29005.11.
16,02016,26005.11.

Aktuelle News zur SMITH & NEPHEW Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoSMITH & NEPHEW PLC - 6-K, Report of foreign issuer3
MoSmith & Nephew Plc - Total Voting Rights3
27.10.Smith & Nephew Slides on Test Studies4
27.10.Smith & Nephew Plc: Smith+Nephew comparative study1 shows PICO? sNPWT (-80 mmHg) delivers superior performance in relation to wound dehiscence and reduces healthcare costs across cardiovascular and orthopedic surgery versus ...472Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces findings from a newly published, first-of-its-kind comparative study of single-use negative pressure wound therapy...
► Artikel lesen
23.10.SMITH & NEPHEW PLC - 6-K, Report of foreign issuer2
22.10.Smith+Nephew extends partnership with UFC as sports medicine partner12
22.10.Smith & Nephew Plc: UFC and Smith+Nephew announce multi-year extension of partnership317Smith+Nephew to continue as UFC's Preferred Sports Medicine Technology Partner Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, and UFC the world's premier mixed martial arts...
► Artikel lesen
22.10.Smith & Nephew Plc - Sterling Amount of Dividend5
SMITH & NEPHEW Aktie jetzt für 0€ handeln
22.10.Smith & Nephew Plc - Dividend Declaration3
20.10.Moody's Upgrades Smith & Nephew (SNN) Long-Term Rating, Citing Strong Revenue and Margin Growth3
20.10.Wachstumsausblick: RBC hebt Kursziel für Smith & Nephew auf 17 GBP an6
20.10.Smith & Nephew stock price target raised to GBP17 by RBC on growth outlook3
16.10.SMITH & NEPHEW PLC - 6-K, Report of foreign issuer2
16.10.Smith+Nephew veröffentlicht Q3-Zwischenbericht 2025 am 6. November6
16.10.Smith+Nephew to release Q3 2025 trading report on November 63
16.10.Smith & Nephew Plc - Notice of Results1
16.10.Sectra adds Smith+Nephew 3D templates to its orthopaedic solution--supporting wider adoption of digital surgical planning238LINKÖPING, Sweden, Oct. 16, 2025 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra(STO: SECT B) has expanded its pre-operative planning solution for...
► Artikel lesen
14.10.Bernstein stuft Smith & Nephew nach Kurserholung herab6
14.10.Smith & Nephew stock rating downgraded by Bernstein as valuation recovers5
09.10.Smith & Nephew Plc: Smith+Nephew announces new category I CPT code for its CARTIHEAL AGILI-C Cartilage Repair Implant325Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces that the American Medical Association (AMA) CPT Editorial Panel has established a Category I Current Procedural...
► Artikel lesen
Weiter >>
130 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1